Clinical trial
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of…
NCT00328601 · MEDA Pharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00328601 |
|---|---|
| Title | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) |
| Official title | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-blind,Placebo-controlled Multicentre Trial With 4 Parallel Groups |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Polyneuropathy |
| Intervention type | Drug |
| Interventions | Thioctic Acid |
| Enrollment | 170 |
| Start date | Feb 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | May 22, 2006 |
| Last update posted | Feb 7, 2022 |
| Countries | Israel, Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: